Ja-Hye Kim

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Gaucher disease is a lysosomal storage disease for which enzyme replacement therapy has proven to be effective. A switch-over clinical trial was performed to evaluate the efficacy and safety of Abcertin® (ISU Abxis, Seoul, Korea) in subjects with type 1 Gaucher disease who were previously treated with imiglucerase. Five Korean patients with type 1 Gaucher(More)
which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The authors want to clarify the definition of " biosimilar " based on " Regulatory expectations and risk assessment for biotherapeutic products. World Health Organization 2014. available from
  • 1